Umbrella Labs Announces GLP-3R, The New Research Designation For Retatrutide, To Support High Rigor Tri-Receptor Endocrine Signaling Bench Science

TUCSON, AZ / ACCESS Newswire / February 26, 2026 / Umbrella Labs today announced an updated research catalog standard that formally presents GLP-3R as the internal research designation for retatrutide ...

Umbrella Labs Tesamorelin Peptide Research Use Only Program Advances High Rigor GHRH Receptor Signaling, GH Axis Modeling, And Endocrine Systems Bench Science

TUCSON, AZ / ACCESS Newswire / February 19, 2026 / Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building ...

Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science

Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment ...
Naturopathic Doctor News and Review

Allergy Research News Release

FOR IMMEDIATE RELEASE Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research ...
The Daily Aztec

Pramorelin: A Ghrelin-Mimetic Peptide at the Frontier of Endocrine and Metabolic Research

Pramorelin, also known in scientific literature as a synthetic ghrelin receptor agonist, has emerged as a notable peptide within the broader landscape of endocrine and metabolic research. Its primary ...
EurekAlert!

GPER signaling: A central driver of Endocrine Therapy resistance in Breast cancer

(A) The AlphaFold protein structure of GPER from the public database (https://alphafold.com/entry/Q99527). (B) E2, the GPER-specific agonist G1, SERMs, and SERDs ...
MedPage Today

For Your Patients: Next Steps if There Is Resistance to Endocrine Therapy

In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...